期刊文献+

冠心病患者对氧磷酶基因多态性分析

The Paraoxonase1-162A/G,-909C/G Polymorphism in Patients with Coronary Heart Disease in Chinese Population
暂未订购
导出
摘要 目的探讨中国人对氧磷酶基因-162A/G-、909C/G遗传多态性与冠心病的关系。方法应用聚合酶链反应对冠心病患者和正常对照者对氧磷酶1基因酶切位点的限制性片段长度多态性进行分析。结果对氧磷酶1-162A/G多态性位点在正常对照组中AA、AG、GG基因型频率及A、G等位基因频率分别为0.047、0.203、0.750和0.148、0.852,冠心病组与对照组基因型分布总体构成比差异无显著性(P>0.05),冠心病组与对照组等位基因频率分布差异也无显著性(P>0.05)。对氧磷酶1-909C/G多态性位点在正常对照组中CC、CG、GG基因型频率及C、G等位基因频率分别为0.258、0.523、0.219和0.520、0.480,冠心病组与对照组基因型频率和等位基因频率差异未见显著性(P>0.05)。冠心病不随两个多态性位点危险基因型个数的增加而发病率呈上升趋势(P>0.05)。结论未发现对氧磷酶1-162A/G和对氧磷酶1-909C/G基因多态性与中国人群冠心病相关联,对氧磷酶1-162A/G和对氧磷酶1-909C/G基因多态性对冠心病的影响无协同性。 Aim To study the association between the polymorphism in the promoter region in human paraoxonase (PON1) gene and coronary heart disease(CHD)in Chinese population. Methods The genotype and allele frequeney of paraoxonasel gene polymorphism were assayed by polymerase chain reaction (PCR)-restrietion fragment length polymorphism (RFLP). Results The frequencies of PONl-162A/G genotype and allele in control were 0.047, 0.203, 0.750 and 0.148, 0.852, respectively. There was no significant difference in genotype and allel frequency between control and CHD group. The frequencies of PON1-909C/G genotype and aUele in control were 0.258, 0.523, 0.219 and 0.520, 0.480, respectively. There wes no significant difference in genotype and allel frequency between control and CHD group. Increasing number of hazardous genotype of PON1 was not associated with CHD. Conclusions These results suggested that PON1-162MG,PON1-909C/G gene polymorphism were not associated with CHD in Chinese population. There was no cooperative effect among these hazardous genotype with CHD.
作者 邵海琴 张英
出处 《中国动脉硬化杂志》 CAS CSCD 2005年第5期619-622,共4页 Chinese Journal of Arteriosclerosis
关键词 内科学 对氧磷酶 启动子 动脉粥样硬化 冠心病 基因型 等位基因频率 Paraoxonase Atherosclerosis Coronary Heart Disease Polymorphism Hazardous Genotype Cooperative Effect
  • 相关文献

参考文献13

  • 1Mackness MI. Commentary A-esterases: enzymes looking for a role? Biochem Pharmacol, 1989, 38 (9): 385-390.
  • 2Brophy VH, Jampsa RL, Clendenning JB, Karam WG. Effects of 5' regulatory-region polymorphisms on paraoxonase-gene(PON1) expression. Am J Hum Genet, 2001, 68 (12): 1 428-436.
  • 3Primo-Parmo SL, Sorenson RC, Teiber J, Stroup D. The human serum paraoxonase/ arylesterase gene(PON1) is one member of a multigene family. Genomics, 1996, 33 (4): 498-509.
  • 4Leviev I, Poirier O, Nicaud V, Wang DP, Miller WF. High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients. Atherosclerosis, 2002, 161 (5): 463-467.
  • 5Chiang JYL, Yang TP, Wang DP. Cloning and 5'-Flanking Sequence of a Rat Cholesterol 7alpha-Hydroxylase Gene. Biochim Biophys Acta, 2003, 132 (3): 337-339.
  • 6Crestani M, Galli G. Genomic cloning, sequencing and analysis of the hamster cholesterol 7alpha-hydroxylase gene (CYP7). Arch Biochem Biophys,2004, 306 (3): 451-460.
  • 7Wang DP. Structure and Nucleotide Sequences of the Human Cholesterol 7alpha-Hydroxylase Gene. Genomics, 2004, 20 (2): 320-323.
  • 8Shih DM, Gu L, Xia YR, Crestani M. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature, 1998, 394 (2): 284-287.
  • 9Serrato M, Marian AJ. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest, 1995, 96 (11): 3 005-008.
  • 10Blatter Garin MC, James RW, Dussoix P, Mackness B, Durrington PN. Paraoxonase polymorphism Met-Leu 54 is assoiciated with modified serum concentrations of the enzyme. J Clin Invest, 1997, 99 (1): 62-65.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部